Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Are Business Services Stocks Lagging  Adecco (AHEXY) This Year?
Are Business Services Stocks Lagging Adecco (AHEXY) This Year?

For those looking to find strong Business Services stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Adecco SA (AHEXY) been one of those stocks this

Why Aptiv PLC (APTV) is a Top Value Stock for the Long-Term
Why Aptiv PLC (APTV) is a Top Value Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year?
Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Encompass Health (EHC) one of those stocks right now? A

Is Shinhan Financial Group Co (SHG) Stock Undervalued Right Now?
Is Shinhan Financial Group Co (SHG) Stock Undervalued Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

UWM Holdings Corporation (UWMC) Beats Q2 Earnings and Revenue Estimates
UWM Holdings Corporation (UWMC) Beats Q2 Earnings and Revenue Estimates

UWM Holdings Corporation (UWMC) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.04 per share a year ago

After Plunging 14.2% in 4 Weeks, Here's Why the Trend Might Reverse for Accel Entertainment (ACEL)
After Plunging 14.2% in 4 Weeks, Here's Why the Trend Might Reverse for Accel Entertainment (ACEL)

A downtrend has been apparent in Accel Entertainment (ACEL) lately with too much selling pressure. The stock has declined 14.2% over the past four weeks. However, given the fact that it is now in

Down 10.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Marex Group PLC (MRX)
Down 10.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Marex Group PLC (MRX)

Marex Group PLC (MRX) has been on a downward spiral lately with significant selling pressure. After declining 10.8% over the past four weeks, the stock looks well positioned for a trend reversal as

IREN Limited (IREN) Just Flashed Golden Cross Signal: Do You Buy?
IREN Limited (IREN) Just Flashed Golden Cross Signal: Do You Buy?

From a technical perspective, IREN Limited (IREN) is looking like an interesting pick, as it just reached a key level of support. IREN recently overtook the 20-day moving average, and this suggests

Down 10.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Nomad Foods (NOMD)
Down 10.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Nomad Foods (NOMD)

Nomad Foods (NOMD) has been beaten down lately with too much selling pressure. While the stock has lost 10.7% over the past four weeks, there is light at the end of the tunnel as it is now in

After Plunging 33.8% in 4 Weeks, Here's Why the Trend Might Reverse for Twist Bioscience (TWST)
After Plunging 33.8% in 4 Weeks, Here's Why the Trend Might Reverse for Twist Bioscience (TWST)

Twist Bioscience (TWST) has been beaten down lately with too much selling pressure. While the stock has lost 33.8% over the past four weeks, there is light at the end of the tunnel as it is now in

Down 15.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Kennametal (KMT)
Down 15.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Kennametal (KMT)

Kennametal (KMT) has been on a downward spiral lately with significant selling pressure. After declining 15.3% over the past four weeks, the stock looks well positioned for a trend reversal as it is

Jackson Financial (JXN) Crossed Above the 20-Day Moving Average: What That Means for Investors
Jackson Financial (JXN) Crossed Above the 20-Day Moving Average: What That Means for Investors

Jackson Financial (JXN) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, JXN crossed above the 20-day moving average

Realty Income Rallies Post-Earnings Miss—Here’s What Drove It
Realty Income Rallies Post-Earnings Miss—Here’s What Drove It

Even after a decline in net earnings per share (EPS), shares of Realty Income Corp. (NYSE: O) are rallying by roughly a point and a half in the pre-market hours the day after they released their

Kenvue (KVUE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Kenvue (KVUE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Kenvue (KVUE) reported $3.84 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 4%. EPS of $0.29 for the same period compares to $0.32 a year ago.

The

Insmed (INSM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Insmed (INSM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2025, Insmed (INSM) reported revenue of $107.42 million, up 18.9% over the same period last year. EPS came in at -$1.70, compared to -$1.94 in the year-ago quarter.

The

Canadian Natural Resources (CNQ) Reports Q2 Earnings: What Key Metrics Have to Say
Canadian Natural Resources (CNQ) Reports Q2 Earnings: What Key Metrics Have to Say

Canadian Natural Resources (CNQ) reported $6.29 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 5%. EPS of $0.51 for the same period compares to $0.64 a

Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2025, Viatris (VTRS) reported revenue of $3.58 billion, down 5.7% over the same period last year. EPS came in at $0.62, compared to $0.69 in the year-ago quarter.

The

Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Prestige Consumer Healthcare (PBH) reported $249.53 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 6.6%. EPS of $0.95 for the same period compares to

Haemonetics (HAE) Reports Q1 Earnings: What Key Metrics Have to Say
Haemonetics (HAE) Reports Q1 Earnings: What Key Metrics Have to Say

Haemonetics (HAE) reported $321.39 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 4.4%. EPS of $1.10 for the same period compares to $1.02 a year ago.

ConocoPhillips (COP) Reports Q2 Earnings: What Key Metrics Have to Say
ConocoPhillips (COP) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, ConocoPhillips (COP) reported revenue of $14.74 billion, up 4.3% over the same period last year. EPS came in at $1.42, compared to $1.98 in the year-ago quarter.

The

Maximus (MMS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Maximus (MMS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2025, Maximus (MMS) reported revenue of $1.35 billion, up 2.6% over the same period last year. EPS came in at $2.16, compared to $1.74 in the year-ago quarter.

The

Compared to Estimates, CDW (CDW) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, CDW (CDW) Q2 Earnings: A Look at Key Metrics

CDW (CDW) reported $5.98 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 10.2%. EPS of $2.60 for the same period compares to $2.50 a year ago.

The

Acushnet (GOLF) Reports Q2 Earnings: What Key Metrics Have to Say
Acushnet (GOLF) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, Acushnet (GOLF) reported revenue of $720.48 million, up 5.4% over the same period last year. EPS came in at $1.25, compared to $1.11 in the year-ago quarter.

The

Restaurant Brands (QSR) Reports Q2 Earnings: What Key Metrics Have to Say
Restaurant Brands (QSR) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, Restaurant Brands (QSR) reported revenue of $2.41 billion, up 15.9% over the same period last year. EPS came in at $0.94, compared to $0.86 in the year-ago quarter.

Compared to Estimates, Collegium Pharmaceutical (COLL) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Collegium Pharmaceutical (COLL) Q2 Earnings: A Look at Key Metrics

Collegium Pharmaceutical (COLL) reported $188 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 29.4%. EPS of $1.68 for the same period compares to $1.62